OTC Pharmaceuticals - Suriname

  • Suriname
  • The OTC Pharmaceuticals market in Suriname is projected to generate revenue of US$14.21m in 2024.
  • It is anticipated to experience an annual growth rate of 4.16% (CAGR 2024-2029).
  • Among the various markets in this market, Other OTC Pharmaceuticals holds the largest share with a market volume of US$8.19m in 2024.
  • In comparison to other countries, the in the United States leads the way in revenue generation, with US$41,240.00m in 2024.
  • When considering the population, per person revenues amount to US$22.60 in 2024.
  • Online sales are expected to contribute 1.05% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • Suriname's OTC Pharmaceuticals market is experiencing a surge in demand for traditional herbal remedies due to cultural preferences and affordability.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Suriname is experiencing steady growth and development due to various factors.

Customer preferences:
Customers in Suriname have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including convenience, accessibility, and affordability. OTC medications are readily available in local pharmacies and supermarkets, allowing customers to easily purchase them without the need for a prescription. Additionally, OTC products are often more affordable compared to prescription medications, making them a popular choice among cost-conscious consumers.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Suriname is the increasing demand for self-medication. As consumers become more health-conscious and seek ways to manage minor ailments and common health issues on their own, the demand for OTC medications has risen. This trend is driven by the growing availability of information through the internet and other sources, empowering consumers to make informed decisions about their health and well-being.Another trend in the market is the expansion of product offerings. Pharmaceutical companies are introducing a wider range of OTC products to cater to the diverse needs of consumers. This includes products for pain relief, cough and cold, digestive health, and skincare, among others. The introduction of new OTC medications provides consumers with more options and allows them to find products that best suit their specific needs.

Local special circumstances:
Suriname has a unique demographic composition, with a diverse population that includes different ethnic groups and cultural backgrounds. This diversity has an impact on the OTC Pharmaceuticals market as it influences consumer preferences and demand. For example, certain ethnic groups may have traditional remedies or preferences for specific types of medications, which can shape the market dynamics. Additionally, the country's geographical location and climate may also influence the types of OTC medications that are in demand, such as products for insect bites or sunburn relief.

Underlying macroeconomic factors:
The development of the OTC Pharmaceuticals market in Suriname is also influenced by underlying macroeconomic factors. Economic stability and growth play a crucial role in driving consumer spending and healthcare expenditure. As the economy improves and disposable incomes rise, consumers are more likely to spend on OTC medications. Furthermore, government policies and regulations also impact the market, including pricing regulations and advertising restrictions. These factors can shape the competitive landscape and market dynamics in Suriname.In conclusion, the OTC Pharmaceuticals market in Suriname is experiencing growth and development due to customer preferences for convenience and affordability, as well as the increasing trend of self-medication. The market is also influenced by local special circumstances, such as the country's diverse population and unique healthcare needs. Underlying macroeconomic factors, including economic stability and government regulations, further shape the market dynamics in Suriname.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)